Osaic Holdings’s Artelo Biosciences ARTL Stock Holding History

Osaic Holdings’s Portfolio ARTL Stock Details ARTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7	Buy	+1	New	+$5	﹤0.01%	7751
2025 Q4	–	Hold	0	–	–	–	7808
2024 Q1	–	Hold	0	–	-$9	–	7200
2023 Q4	–	Hold	0	–	–	–	7237
2021 Q4	–	Hold	0	–	–	–	7362
2021 Q3	–	Hold	0	–	–	–	7165
2021 Q2	–	Hold	0	–	–	–	6976
2021 Q1	–	Hold	0	–	–	–	6788

Other funds holding ARTL

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

KCM

Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

RIL

Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Osaic Holdings's ARTL Position: Q1 2026 in Review

Osaic Holdings opened a new position in Artelo Biosciences (ARTL) in Q1 2026: 1 share worth $7. The stake represents ﹤0.01% of the portfolio and ranks #7751 among its holdings.

11 funds tracked by Wall St. Rank hold ARTL as of Q1 2026.

Osaic Holdings held 1 share of Artelo Biosciences worth $7 as of Q1 2026.
Artelo Biosciences was a new Osaic Holdings position in Q1 2026.
Artelo Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7751 holding.
11 funds tracked by Wall St. Rank held Artelo Biosciences as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.